Si­nos pre­par­ing vs se­cond virus wave

The China solution will be to en­sure 100 per­cent med­i­cal quar­an­tine for con­firmed and sus­pected cases with full sup­port of the pub­lic to con­trol a pos­si­ble se­cond wave

Daily Tribune (Philippines) - - WORLD -

SHANG­HAI (China Daily) — Ex­perts have re­it­er­ated the im­por­tance of stay­ing highly alert for a pos­si­ble se­cond COVID-19 epi­demic in China, since such out­breaks have been go­ing on for weeks in some Euro­pean coun­tries.

“The pan­demic will linger for at least an­other year be­fore vac­cines are avail­able,” said Zhang Wen­hong, leader of the Shang­hai team of ex­perts in the clin­i­cal treat­ment of novel coro­n­avirus pneu­mo­nia cases.

The China solution will be to en­sure 100 per­cent med­i­cal quar­an­tine for con­firmed and sus­pected cases with full sup­port of the pub­lic to con­trol a pos­si­ble se­cond wave.

The China solution will be to en­sure 100 per­cent med­i­cal quar­an­tine for con­firmed and sus­pected cases with full sup­port of the pub­lic to con­trol a pos­si­ble se­cond wave.

“If not, the num­ber of cases will climb to form an ex­po­nen­tial curve,” Zhang who is also di­rec­tor of the depart­ment of in­fec­tious dis­eases at Shang­hai Huashan Hos­pi­tal Af­fil­i­ated with Fu­dan Univer­sity said at a pub­lic health fo­rum at Shang­hai Jiao Tong Univer­sity on Sun­day.

Zhong Nan­shan, a lead­ing res­pi­ra­tory dis­ease expert and re­cip­i­ent of the Medal of the Repub­lic for his con­tri­bu­tion to the na­tional epi­demic con­trol, also said that the pan­demic may per­sist un­til win­ter or even spring next year.

“Chances are that dis­ease clus­ters will hap­pen in some ar­eas at home and abroad,” Zhong said, adding that mea­sures, in­clud­ing com­mu­nity epi­demic con­trol, nu­cleic acid tests among com­mu­nity res­i­dents, trac­ing close con­tacts and strict quar­an­tine im­ple­men­ta­tion for asymp­to­matic cases, should fol­low.

He made the re­marks via video at a global science and health­care sub­fo­rum of the Zhong­guan­cun Fo­rum in Beijing on Fri­day.

China is still un­der threat of im­ported cases, Zhang said.

The na­tional expert team is be­ing dis­patched to var­i­ous prov­inces and mu­nic­i­pal­i­ties these days to ex­am­ine and su­per­vise lo­cal preven­tion and treat­ment ef­forts of in­fec­tious dis­eases, and thus cut off im­ported cases from any pos­si­ble do­mes­tic links that could trig­ger a dis­ease out­break lo­cally, he said.

It will still be at least a year be­fore highly an­tic­i­pated novel coro­n­avirus vac­cines are avail­able to the pub­lic as the world’s pub­lic health ex­perts fore­cast that the vac­cines will be first de­ployed in mid-2021 based on op­ti­mistic es­ti­mates and in­ter­na­tional col­lab­o­ra­tion.

Zhang ex­plained that af­ter the re­search and de­vel­op­ment phase, it takes time to get the vac­cines ready for mass pro­duc­tion and build sup­ply chains for sales.

Newspapers in English

Newspapers from Philippines

© PressReader. All rights reserved.